Form 4 for WST West Pharmaceutical Services
Accepted 2026-02-23 00:00:00 ET · period of report 2026-02-20 · accession 0000105770-26-000025 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2026-02-23 | 2026-02-20 | WST | Poussot Rodolphe Jean | SVP, Strategy, Corp. Dev | F - Tax | $241.12 | -129.55 | 561.24 | -19% | -$31.2K |
| D | 2026-02-23 | 2026-02-20 | WST | Poussot Rodolphe Jean | SVP, Strategy, Corp. Dev | M - OptEx | — | +383.38 | 690.78 | +125% | — |
| D | 2026-02-23 | 2026-02-20 | WST | Poussot Rodolphe Jean | SVP, Strategy, Corp. Dev | M - OptEx | $0.00 | -383.38 | 383.36 | -50% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2026-02-20 | F | D | 129.55 | $241.12 | 561.24 | D | — | — | |
| 2 | Common | Common Stock | 2026-02-20 | M | A | 383.38 | — | 690.78 | D | — | — | (F1) Restricted stock units convert into common stock on a one-for-one basis. |
| 3 | Derivative | Rst. Stock Unit | 2026-02-20 | M | D | 383.38 | $0.00 | 383.36 | D | — · — to — | 383.38 Common Stock | (F1) Restricted stock units convert into common stock on a one-for-one basis. (F2) On February 20, 2024, the reporting person was granted 1,143 restricted stock units, vesting in three equal annual installments (plus dividend equivalents). |